Pill to `block` arthritis comes closer to reality
London: Scientists have come closer to developing a potent pain-busting pill that could revolutionise treatment for arthritis with the discovery of a “master molecule” that acts as a messenger, helping fuel cells at the site of inflammation.
The protein GM-CSF is unique to arthritis and plays a role in the defective immune system response that leads to the disorder.
Now, experts believe that blocking the action of the vital protein could lead to a new treatment for the painful inflammatory disease.
Professor John Hamilton who led the research at the University of Melbourne in Australia, said that not only can blocking GM-CSF, which is also known as Leukine, suppress the actual disease, it can also reduce pain in sufferers.